BOEHRINGER-INGELHEIM
20.12.2022 14:46:38 CET | Business Wire | Press release
Boehringer Ingelheim today announces that the Shareholders have appointed Paola Casarosa and Shashank Deshpande to the Board of Managing Directors. They will succeed Michel Pairet, responsible for the Innovation Unit, and Jean Scheftsik de Szolnok, responsible for the Animal Health Business Unit, who informed the Shareholders of their wish to retire at the end of next year.
Paola Casarosa will succeed Michel Pairet to head the Innovation Unit. Paola joined Boehringer Ingelheim in 2007 and is currently Global Head of Therapeutic Areas in the Human Pharma Business Unit. Prior to this role, she held various leadership roles in Business Development and in Research. Paola is an Italian national, holds a PhD in Molecular Pharmacology and a Masters’ degree in Medicinal Chemistry.
Shashank Deshpande will succeed Jean Scheftsik de Szolnok to head the Animal Health Business Unit. Shashank joined Boehringer Ingelheim in 2012 and is currently Country Managing Director Japan. Prior to this role he held several leadership and marketing positions in Japan and Ingelheim. A German and US national, Shashank holds a Masters’ degree in Business Administration.
Christian Boehringer, Chairman of the Shareholders’ Committee said: “Our long-term planning allows for a seamless transition. On behalf of the Shareholders, I want to thank Michel and Jean for their many years of dedication to our company and I congratulate Paola and Shashank on their appointments.”
Hubertus von Baumbach, Chairman of the Board of Managing Directors, added: “I am grateful for the long time that I have had the privilege to work with Michel and Jean and I look forward to continuing to work with them until the end of 2023. The Board is excited to welcome Paola and Shashank to the team later next year.”
The appointment to the Board of Managing Directors will be effective July 1, 2023 for Paola Casarosa and September 1, 2023 for Shashank Deshpande.
Click here for the full release: https://www.boehringer-ingelheim.com/about-us/boehringer-ingelheim-appointment-board-managing-directors
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221220005424/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Grid Dynamics Launches AI-Native Modernization on Azure, Targeting Larger Enterprise Deals19.5.2026 22:05:00 CEST | Press release
Key Takeaways: New offerings target modernization of large enterprises running mission-critical, high-transaction-volume legacy environments. As a Microsoft Azure specialized partner with five advanced specializations, including Infra & Database Migration, Grid Dynamics’ clients will receive free deployment support through the Azure Accelerate program. Built on the GAIN (Grid Dynamics AI-Native) Platform for SDLC, which has delivered 30%+ productivity gains in our benchmarks. Grid Dynamics extends its AI delivery model to Azure, drawing on extensive expertise in application migration for Fortune 1000 companies. In the first quarter of 2026, AI represented 29% of the company’s revenue. This was up from 25% in 2025 and was driven by deployments across industry verticals, including Technology, Financial Services, CPG, and Manufacturing. Grid Dynamics Holdings, Inc. (Nasdaq: GDYN) (“Grid Dynamics”), a premier AI transformation partner for the Fortune 1000, today announced an AI-native mode
Vultr Expands European Footprint with 33rd Cloud Data Center Region in Milan, Italy19.5.2026 17:28:00 CEST | Press release
New region strengthens Vultr's commitment to affordable, high-performance cloud infrastructure and Europe's thriving open source and AI ecosystem Vultr, the world’s largest privately-held cloud infrastructure company, today announces the launch of its 33rd global cloud data center region in Milan, coinciding with AI Week 2026 at Fiera Milano Rho, where over 700 international speakers will gather for Europe's largest AI event. Vultr is a platinum sponsor and is also co-hosting the AI Agent Olympics Hackathon with over 1,000 participants. Milan becomes Vultr's ninth European cloud data center region, joining Amsterdam, Frankfurt, London, Madrid, Manchester, Paris, Stockholm, and Warsaw. This launch represents the company's latest expansion of a global network reaching 90% of the world's population within 2–40 milliseconds. Vultr’s cloud data center location will be delivering Vultr’s full-stack AI infrastructure, including Vultr’s flagship cloud compute offering, VX1, in addition to Vult
Global Millennial Capital Closes USD 100 Million IPO Opportunities Fund Focused on AI, Decentralized Financial Infrastructure, and Climate Technologies19.5.2026 17:16:00 CEST | Press release
Global Millennial Capital Ltd. (“GMCL”) today announced the final closing of its inaugural IPO Opportunities Fund at USD 100 million. Raised through a private placement with institutional and professional investors, the fund targets late-stage and special opportunities investments across mid-cap technology companies operating in high-growth sectors, including artificial intelligence, decentralized finance infrastructure, cybersecurity, digital infrastructure, enterprise software, and climate technologies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260519513523/en/ Global Millennial Capital announces the successful final close of its USD 100 million IPO Opportunities Fund, reinforcing its commitment to investing in high-growth technology companies across artificial intelligence, digital infrastructure, cybersecurity, and next-generation financial systems. The fund is designed to capitalize on the increasing number of tech
Miro Takes Aim at the Gap Between AI Potential and Organizational Reality19.5.2026 16:00:00 CEST | Press release
At Canvas 26, Miro establishes its AI platform as the connective layer of the modern AI ecosystem — bringing together teams, agents, and the tools they already work in to turn individual AI productivity into organization-wide transformation Miro®, the AI Innovation Workspace for teams, has announced new innovations across its AI platform, reinforcing its position as the collaboration layer where people, context, and agents from every function converge to solve hard problems, make better decisions, and build the right thing faster. Major upgrades to Miro’s agentic AI tools — including Sidekicks and Flows — alongside new Connectors, help customers close the gap between individual AI productivity and organization-wide transformation. AI is reshaping the pace of work, but often teams are not realising the benefits. In many organizations, a gap has emerged between what individuals can now do and what companies can harness. The reason? Collaboration has fractured. Teams have moved from one m
Wolters Kluwer Medi-Span Selected to Provide Personalized Medication Decision Support at The Christie NHS Foundation Trust19.5.2026 15:30:00 CEST | Press release
Roll-out at largest EU cancer center marks first Medi-Span NHS implementation Wolters Kluwer Health has implemented its industry-leading medication decision support (MDS) solution, Medi-Span®, at the world-renowned specialist oncology center, The Christie NHS Foundation Trust. “The Christie is recognized globally for its excellence and commitment to delivering exceptional patient care,” says Israel Armstrong, Vice President for Medi-Span International at Wolters Kluwer Health. “We’re proud that our first Medi-Span implementation in the NHS should be with such a prestigious institution. We look forward to more collaborations that help streamline processes further and help clinical teams make the most highly informed decisions.” The Christie is a leading expert in cancer care, research and education and is the largest single-site cancer center in Europe. The Christie treats more than 60,000 patients a year and is the first facility in the UK to be accredited as a comprehensive cancer cen
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom